Warfarin Dose Adjustment for INR 1.9
Increase your total weekly warfarin dose by 10-15% and recheck your INR in 1-2 weeks. 1
Current Situation Analysis
Your current regimen alternating between 5 mg and 7.5 mg equals a weekly dose of 43.75 mg (assuming you alternate throughout the week). An INR of 1.9 is slightly below the standard therapeutic target of 2.0-3.0 for most indications 1.
Recommended Dose Adjustment Strategy
Since your INR is only marginally subtherapeutic (1.9 vs target ≥2.0), this represents a slightly out-of-range value in what appears to be a previously stable patient. The evidence supports two reasonable approaches:
Option 1: Modest Weekly Dose Increase (Preferred)
- Increase your total weekly dose by 10-15% (approximately 4.4-6.6 mg more per week)
- Practical adjustment: Add an extra 1.25 mg on one or two days per week, OR increase one of your alternating doses from 5 mg to 6.25 mg
- This translates to approximately 48-50 mg weekly total
- Recheck INR in 1-2 weeks 2, 3
Option 2: Watchful Waiting
Recent evidence suggests that for slightly out-of-range INRs (1.5-1.99), continuing the same dose with close monitoring is also reasonable 4, 5. However, this approach showed only marginally lower success rates (58.9% vs 60.0% return to therapeutic range) compared to dose adjustment 4.
Key Clinical Considerations
The guideline framework is clear: When INR is below therapeutic range but >1.5 without bleeding, you can either reduce the dose slightly or omit the next dose and resume at lower dosing when approaching target 2. However, since your INR is 1.9 (very close to 2.0), aggressive intervention is not warranted.
Important caveats:
- Do NOT use bridging anticoagulation (like low-molecular-weight heparin) for a single subtherapeutic INR of 1.9 - this is not indicated for most patients 6
- Most dose adjustments should alter total weekly dose by 5-20% 3
- Avoid making changes for every minor fluctuation - single slightly out-of-range values don't always require adjustment in stable patients 5
Monitoring Schedule
- Recheck INR in 1-2 weeks after any dose change 2, 3
- Once stable in therapeutic range for 2 consecutive measurements, you can extend to every 2-4 weeks 2
- Eventually, stable patients can be monitored every 4-6 weeks 3
Practical Implementation
Your alternating dose regimen (5 mg/7.5 mg) is a valid approach and performs comparably to split-tablet daily dosing 7. To implement a 10-15% increase:
- Simple option: Change your schedule to 5 mg on 3 days and 7.5 mg on 4 days (instead of alternating evenly)
- Alternative: Increase to 6.25 mg on some days instead of 5 mg
The evidence shows that both approaches (dose adjustment vs. watchful waiting) have similar outcomes for slightly out-of-range INRs 4, 5, but given that you're seeking guidance for adjustment, a modest 10-15% weekly increase is the most evidence-based intervention that balances efficacy with safety 3.